Have a personal or library account? Click to login
Influence of nutritional status and body composition on postoperative events and outcome in patients treated for primary localized retroperitoneal sarcoma Cover

Influence of nutritional status and body composition on postoperative events and outcome in patients treated for primary localized retroperitoneal sarcoma

Open Access
|Feb 2024

References

  1. Van Tine BA. 90 - Sarcomas of soft tissue. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, editors. Abeloff's clinical oncology (Sixth Edition). Philadelphia: Elsevier; 2019. p. 1655-93.e11.
  2. Stiller CA, Trama A, Serraino D, Rossi S, Navarro C, Chirlaque MD, et al. Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 2013; 49: 684–95. doi: <a href="https://doi.org/10.1016/j.ejca.2012.09.011" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejca.2012.09.011</a>
  3. Gholami S, Jacobs CD, Kapp DS, Parast LM, Norton JA. The value of surgery for retroperitoneal sarcoma. Sarcoma 2009; 2009: 605840. doi: <a href="https://doi.org/10.1155/2009/605840" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1155/2009/605840</a>
  4. Trans-Atlantic RPSWG. Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2015; 22: 256–63. doi: <a href="https://doi.org/10.1245/s10434-014-3965-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-014-3965-2</a>
  5. Trans-Atlantic RPSWG. Erratum to: Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol 2017; 24: 688–9. doi: <a href="https://doi.org/10.1245/s10434-017-5889-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-017-5889-0</a>
  6. Bonvalot S, Gronchi A, Le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 2020; 21: 1366–77. doi: <a href="https://doi.org/10.1016/s1470-2045(20)30446-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s1470-2045(20)30446-0</a>
  7. Bonvalot S, Gronchi A, Le Pechoux C, Swallow CJ, Strauss DC, Meeus P, et al. STRASS (EORTC 62092): a phase III randomized study of preoperative radio-therapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. [abstract]. J Clin Oncol 2019; 37(15 Sppl): 11001. doi: <a href="https://doi.org/10.1200/JCO.2019.37.15_suppl.11001" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/JCO.2019.37.15_suppl.11001</a>
  8. Callegaro D, Raut CP, Ajayi T, Strauss D, Bonvalot S, Ng D, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 Trial (STRASS) versus off-trial (STREXIT) results. Ann Surg 2023; 278: 127–34. doi: <a href="https://doi.org/10.1097/sla.0000000000005492" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/sla.0000000000005492</a>
  9. Bonvalot S, Raut CP, Pollock RE, Rutkowski P, Strauss DC, Hayes AJ, et al. Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-Surge, a master class in sarcoma surgery, and EORTC-STBSG. Ann Surg Oncol 2012; 19: 2981–91. doi: <a href="https://doi.org/10.1245/s10434-012-2342-2" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-012-2342-2</a>
  10. Bonvalot S, Rivoire M, Castaing M, Stoeckle E, Le Cesne A, Blay JY, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009; 27: 31–7. doi: <a href="https://doi.org/10.1200/jco.2008.18.0802" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/jco.2008.18.0802</a>
  11. Gutierrez JC, Perez EA, Moffat FL, Livingstone AS, Franceschi D, Koniaris LG. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients. Ann Surg 2007; 245: 952–8. doi: <a href="https://doi.org/10.1097/01.sla.0000250438.04393.a8" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/01.sla.0000250438.04393.a8</a>
  12. van Dalen T, Hennipman A, Van Coevorden F, Hoekstra HJ, van Geel BN, Slootweg P, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol 2004; 11: 483–90. doi: <a href="https://doi.org/10.1245/aso.2004.09.005" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/aso.2004.09.005</a>
  13. Andritsch E, Beishon M, Bielack S, Bonvalot S, Casali P, Crul M, et al. ECCO Essential Requirements for Quality Cancer Care: soft tissue sarcoma in adults and bone sarcoma. A critical review. Crit Rev Oncol Hematol 2017; 110: 94–105. doi: <a href="https://doi.org/10.1016/j.critrevonc.2016.12.002" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.critrevonc.2016.12.002</a>
  14. Novak M, Perhavec A, Povšič M, Arnuš M, Eržen D. Primary localized retroperitoneal sarcomas: report from Slovenian sarcoma referral center. World J Surg Oncol 2020; 18: 277. doi: <a href="https://doi.org/10.1186/s12957-020-02038-9" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1186/s12957-020-02038-9</a>
  15. Balderas-Pena LM, Gonzalez-Barba F, Martinez-Herrera BE, Palomares-Chacon UR, Duran-Anguiano O, Salazar-Paramo M, et al. Body composition and biochemical parameters of nutritional status: correlation with health-related quality of life in patients with colorectal cancer. Nutrients 2020; 12: 2110. doi: <a href="https://doi.org/10.3390/nu12072110" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/nu12072110</a>
  16. Arends J, Baracos V, Bertz H, Bozzetti F, Calder PC, Deutz NEP, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutri 2017; 36: 1187–96. doi: <a href="https://doi.org/10.1016/j.clnu.2017.06.017" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.clnu.2017.06.017</a>
  17. Kirov KM, Xu HP, Crenn P, Goater P, Tzanis D, Bouhadiba MT, et al. Role of nutritional status in the early postoperative prognosis of patients operated for retroperitoneal liposarcoma (RLS): a single center experience. Eur J Surg Oncol 2019; 45: 261–7. doi: <a href="https://doi.org/10.1016/j.ejso.2018.07.001" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejso.2018.07.001</a>
  18. Previtali P, Fiore M, Colombo J, Arendar I, Fumagalli L, Pizzocri M, et al. Malnutrition and perioperative nutritional support in retroperitoneal sarcoma patients: results from a prospective study. Ann Surg Oncol 2020; 27: 2025–32. doi: <a href="https://doi.org/10.1245/s10434-019-08121-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-019-08121-0</a>
  19. Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 2018; 23: 97–104. doi: <a href="https://doi.org/10.1634/theoncologist.2017-0255" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1634/theoncologist.2017-0255</a>
  20. Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2016; 17: 767.e1–7. doi: <a href="https://doi.org/10.1016/j.jamda.2016.05.016" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jamda.2016.05.016</a>
  21. Czigany Z, Kramp W, Bednarsch J, van der Kroft G, Boecker J, Strnad P, et al. Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation. Am J Transplant 2020; 20: 493–503. doi: <a href="https://doi.org/10.1111/ajt.15577" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/ajt.15577</a>
  22. Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, Rautio T, Ohtonen P, Saarnio J, et al. The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study. Eur J Surg Oncol 2020; 46: 1656–62. doi: <a href="https://doi.org/10.1016/j.ejso.2020.03.206" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejso.2020.03.206</a>
  23. Rier HN, Jager A, Sleijfer S, Maier AB, Levin MD. The prevalence and prognostic value of low muscle mass in cancer patients: a review of the literature. Oncologist 2016; 21: 1396–409. doi: <a href="https://doi.org/10.1634/theoncologist.2016-0066" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1634/theoncologist.2016-0066</a>
  24. Deng CY, Lin YC, Wu JS, Cheung YC, Fan CW, Yeh KY, et al. Progressive sarcopenia in patients with colorectal cancer predicts survival. AJR Am J Roentgenol 2018; 210: 526–32. doi: <a href="https://doi.org/10.2214/ajr.17.18020" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2214/ajr.17.18020</a>
  25. Jung AR, Roh JL, Kim JS, Kim SB, Choi SH, Nam SY, et al. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer. Eur J Cancer 2019; 116: 98–106. doi: <a href="https://doi.org/10.1016/j.ejca.2019.05.006" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.ejca.2019.05.006</a>
  26. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629–35. doi: <a href="https://doi.org/10.1016/S1470-2045(08)70153-0" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S1470-2045(08)70153-0</a>
  27. Strassmann D, Hensen B, Grünwald V, Stange K, Eggers H, Länger F, et al. Impact of sarcopenia in advanced and metastatic soft tissue sarcoma. Int J Clin Oncol 2021; 26: 2151–60. doi: <a href="https://doi.org/10.1007/s10147-021-01997-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s10147-021-01997-7</a>
  28. Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes 2014; 21: 345–51. doi: <a href="https://doi.org/10.1097/med.0000000000000093" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/med.0000000000000093</a>
  29. Boyle EA, Elliott JA, McIntyre TV, Barnes ME, Donlon NE, Umair M, et al. Body composition is associated with operative and oncologic outcomes in the management of retroperitoneal and trunk soft tissue sarcoma. Am J Surg 2022; 223: 729–37. doi: <a href="https://doi.org/10.1016/j.amjsurg.2021.08.005" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.amjsurg.2021.08.005</a>
  30. O'Sullivan J, Lysaght J, Donohoe CL, Reynolds JV. Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments. Nat Rev Gastroenterol Hepatol 2018; 15: 699–714. doi: <a href="https://doi.org/10.1038/s41575-018-0069-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/s41575-018-0069-7</a>
  31. Shirazipour CH, Freedland SJ. Obesity, visceral adiposity, and prostate cancer: what is the role of lifestyle interventions? Cancer 2019; 125: 2730–1. doi: <a href="https://doi.org/10.1002/cncr.32165" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/cncr.32165</a>
  32. Baastrup NN, Christensen JK, Jensen KK, Jørgensen LN. Visceral obesity and short-term outcomes after laparoscopic rectal cancer resection. Surg Endosc 2020; 34: 177–85. doi: <a href="https://doi.org/10.1007/s00464-019-06748-4" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00464-019-06748-4</a>
  33. Silveira EA, Kliemann N, Noll M, Sarrafzadegan N, de Oliveira C. Visceral obesity and incident cancer and cardiovascular disease: an integrative review of the epidemiological evidence. Obes Rev 2021; 22: e13088. doi: <a href="https://doi.org/10.1111/obr.13088" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1111/obr.13088</a>
  34. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yagi S, et al. Impact of skeletal muscle mass index, intramuscular adipose zissue content, and visceral to subcutaneous adipose tissue area ratio on early mortality of living donor liver transplantation. Transplantation 2017; 101: 565–74. doi: <a href="https://doi.org/10.1097/tp.0000000000001587" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/tp.0000000000001587</a>
  35. Okamura A, Watanabe M, Mine S, Nishida K, Imamura Y, Kurogochi T, et al. Clinical impact of abdominal fat distribution on prognosis after esophagectomy for esophageal squamous cell carcinoma. Ann Surg Oncol 2016; 23: 1387–94. doi: <a href="https://doi.org/10.1245/s10434-015-5018-x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-015-5018-x</a>
  36. Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, et al. Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma. Liver Cancer 2019; 8: 92–109. doi: <a href="https://doi.org/10.1159/000488779" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1159/000488779</a>
  37. Grignol VP, Smith AD, Shlapak D, Zhang X, Del Campo SM, Carson WE. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy. Surg Oncol 2015; 24: 353–8. doi: <a href="https://doi.org/10.1016/j.suronc.2015.09.002" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.suronc.2015.09.002</a>
  38. Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 2018; 29: ii1–9. doi: <a href="https://doi.org/10.1093/annonc/mdx810" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/annonc/mdx810</a>
  39. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr 2022; 41: 990–1000. doi: <a href="https://doi.org/10.1016/j.clnu.2021.11.014" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.clnu.2021.11.014</a>
  40. Vehmas T, Kairemo KJ, Taavitsainen MJ. Measuring visceral adipose tissue content from contrast enhanced computed tomography. Int J Obes Relat Metab Disord 1996; 20: 570–3. PMID: 8782734
  41. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85: 115–22. doi: <a href="https://doi.org/10.1152/jappl.1998.85.1.115" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1152/jappl.1998.85.1.115</a>
  42. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes 2007; 31: 500–6. doi: <a href="https://doi.org/10.1038/sj.ijo.0803454" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/sj.ijo.0803454</a>
  43. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008; 33: 997–1006. doi: <a href="https://doi.org/10.1139/H08-075" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1139/H08-075</a>
  44. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205–13. doi: <a href="https://doi.org/10.1097/01.sla.0000133083.54934.ae" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1097/01.sla.0000133083.54934.ae</a>
  45. Trojani M, Contesso G, Coindre JM, Rouesse J, Bui NB, de Mascarel A, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37–42. doi: <a href="https://doi.org/10.1002/ijc.2910330108" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/ijc.2910330108</a>
  46. Popuri K, Cobzas D, Esfandiari N, Baracos V, Jägersand M. Body composition assessment in axial CT images using FEM-based automatic segmentation of skeletal muscle. IEEE Trans Med Imaging 2016; 35: 512–20. doi: <a href="https://doi.org/10.1109/tmi.2015.2479252" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1109/tmi.2015.2479252</a>
  47. Doyle SL, Bennett AM, Donohoe CL, Mongan AM, Howard JM, Lithander FE, et al. Establishing computed tomography – defined visceral fat area thresholds for use in obesity – related cancer research. Nutr Res 2013; 33: 171–9. doi: <a href="https://doi.org/10.1016/j.nutres.2012.12.007" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.nutres.2012.12.007</a>
  48. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 601. doi: <a href="https://doi.org/10.1093/ageing/afz046" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1093/ageing/afz046</a>
  49. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489–95. doi: <a href="https://doi.org/10.1016/s1470-2045(10)70218-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/s1470-2045(10)70218-7</a>
  50. Contal C, O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal 1999; 30: 253–70. doi: <a href="https://doi.org/10.1016/S0167-9473(98)00096-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/S0167-9473(98)00096-6</a>
  51. Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E, et al. Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev 2017; 26: 1008–15. doi: <a href="https://doi.org/10.1158/1055-9965.Epi-17-0200" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1158/1055-9965.Epi-17-0200</a>
  52. Hassen W, Kassambara A, Reme T, Sahota S, Seckinger A, Vincent L, et al. Drug metabolism and clearance system in tumor cells of patients with multiple myeloma. Oncotarget 2015; 6: 6431–47. doi: <a href="https://doi.org/10.18632/oncotarget.3237" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.18632/oncotarget.3237</a>
  53. Kassambara A, Gourzones-Dmitriev C, Sahota S, Reme T, Moreaux J, Goldschmidt H, et al. A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy. Oncotarget 2014; 5: 2487–98. doi: <a href="https://doi.org/10.18632/oncotarget.1740" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.18632/oncotarget.1740</a>
  54. He WZ, Jiang C, Liu LL, Yin CX, Rong YM, Hu WM, et al. Association of body composition with survival and inflammatory responses in patients with nonmetastatic nasopharyngeal cancer. Oral Oncology 2020; 108: 104771. doi: <a href="https://doi.org/10.1016/j.oraloncology.2020.104771" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.oraloncology.2020.104771</a>
  55. Caan BJ, Feliciano EMC, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol 2018; 4: 798–804. doi: <a href="https://doi.org/10.1001/jamaoncol.2018.0137" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1001/jamaoncol.2018.0137</a>
  56. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992; 48: 73–85. doi: <a href="https://doi.org/10.2307/2532740" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2307/2532740</a>
  57. Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr 2017; 36: 49–64. doi: <a href="https://doi.org/10.1016/j.clnu.2016.09.004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.clnu.2016.09.004</a>
  58. Fujiwara N, Nakagawa H, Kudo Y, Tateishi R, Taguri M, Watadani T, et al. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 2015; 63: 131–40. doi: <a href="https://doi.org/10.1016/j.jhep.2015.02.031" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jhep.2015.02.031</a>
  59. McSorley ST, Black DH, Horgan PG, McMillan DC. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin Nutr 2018; 37: 1279–85. doi: <a href="https://doi.org/10.1016/j.clnu.2017.05.017" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.clnu.2017.05.017</a>
  60. Martin L, Birdsell L, MacDonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013; 31: 1539–47. doi: <a href="https://doi.org/10.1200/jco.2012.45.2722" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1200/jco.2012.45.2722</a>
  61. Srpcic M, Jordan T, Popuri K, Sok M. Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer. Radiol Oncol 2020; 54: 237–46. doi: <a href="https://doi.org/10.2478/raon-2020-0016" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2478/raon-2020-0016</a>
  62. Aleixo GFP, Shachar SS, Nyrop KA, Muss HB, Malpica L, Williams GR. Myosteatosis and prognosis in cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol 2020; 145: 102839. doi: <a href="https://doi.org/10.1016/j.critrevonc.2019.102839" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.critrevonc.2019.102839</a>
  63. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev 2001; 2: 141–7. doi: <a href="https://doi.org/10.1046/j.1467-789x.2001.00031.x" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1046/j.1467-789x.2001.00031.x</a>
  64. Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Kamo N, et al. Impact of visceral adiposity as well as sarcopenic factors on outcomes in patients undergoing liver resection for colorectal liver metastases. World J Surg 2018; 42: 1180–91. doi: <a href="https://doi.org/10.1007/s00268-017-4255-5" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s00268-017-4255-5</a>
  65. Rickles AS, Iannuzzi JC, Mironov O, Deeb AP, Sharma A, Fleming FJ, et al. Visceral obesity and colorectal cancer: are we missing the boat with BMI? J Gastrointest Surg 2013; 17: 133–43; discussion p.43. doi: <a href="https://doi.org/10.1007/s11605-012-2045-9" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s11605-012-2045-9</a>
  66. Smith AD, Gray MR, del Campo SM, Shlapak D, Ganeshan B, Zhang X, et al. Predicting overall survival in patients with metastatic melanoma on antiangiogenic therapy and RECIST stable disease on initial posttherapy images using CT texture analysis. AJR Am J Roentgenol 2015; 205: W283–93. doi: <a href="https://doi.org/10.2214/ajr.15.14315" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2214/ajr.15.14315</a>
  67. Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, et al. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015; 157: 1088–98. doi: <a href="https://doi.org/10.1016/j.surg.2015.02.002" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.surg.2015.02.002</a>
  68. He AQ, Li CQ, Zhang Q, Liu T, Liu J, Liu G. Visceral-to-subcutaneous fat ratio is a potential predictor of postoperative complications in colorectal cancer. Med Sci Monit 2021; 27: e930329. doi: <a href="https://doi.org/10.12659/msm.930329" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.12659/msm.930329</a>
  69. Tran TT, Yamamoto Y, Gesta S, Kahn CR. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 2008; 7: 410–20. doi: <a href="https://doi.org/10.1016/j.cmet.2008.04.004" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.cmet.2008.04.004</a>
  70. Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, et al. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer 2017; 117: 148–55. doi: <a href="https://doi.org/10.1038/bjc.2017.149" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1038/bjc.2017.149</a>
  71. Ebadi M, Baracos VE, Bathe OF, Robinson LE, Mazurak VC. Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content. Clin Nutr 2016; 35: 1347–53. doi: <a href="https://doi.org/10.1016/j.clnu.2016.02.014" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.clnu.2016.02.014</a>
  72. Di Prata C, Renouf B, Tzanis D, Bouhadiba T, Watson S, Zein SE, et al. Significant predictors of postoperative morbidity after radical resection of retroperitoneal sarcoma in a tertiary center. Ann Surg Oncol 2023; 30: 4515–26. doi: <a href="https://doi.org/10.1245/s10434-023-13459-7" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-023-13459-7</a>
  73. Nasirishargh A, Grova M, Bateni CP, Judge SJ, Nuno MA, Basmaci UN, et al. Sarcopenia and frailty as predictors of surgical morbidity and oncologic outcomes in retroperitoneal sarcoma. J Surg Oncol 2023; 127: 855–61. doi: <a href="https://doi.org/10.1002/jso.27199" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/jso.27199</a>
  74. Choi ES, Kim HS, Han I. Elevated preoperative systemic inflammatory markers predict poor outcome in localized soft tissue sarcoma. Ann Surg Oncol 2014; 21: 778–85. doi: <a href="https://doi.org/10.1245/s10434-013-3418-3" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-013-3418-3</a>
  75. Fiore M, Ljevar S, Pasquali S, Morelli D, Callegaro D, Sanfilippo R, et al. Preoperative neutrophil-to-lymphocyte ratio and a new inflammatory biomarkers prognostic index for primary retroperitoneal sarcomas: retrospective monocentric study. Clin Cancer Res 2023; 29: 614–20. doi: <a href="https://doi.org/10.1158/1078-0432.CCR-22-2897" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1158/1078-0432.CCR-22-2897</a>
  76. Schwartz PB, Poultsides G, Roggin K, Howard JH, Fields RC, Clarke CN, et al. PLR and NLR are poor predictors of survival outcomes in sarcomas: a new perspective from the USSC. J Surg Res 2020; 251: 228–38. doi: <a href="https://doi.org/10.1016/j.jss.2020.01.008" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1016/j.jss.2020.01.008</a>
  77. Netanyahu Y, Gerstenhaber F, Shamai S, Sher O, Merimsky O, Klausner JM, et al. Innate inflammatory markers for predicting survival in retroperitoneal sarcoma. J Surg Oncol 2020; 122: 1655–61. doi: <a href="https://doi.org/10.1002/jso.26178" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1002/jso.26178</a>
  78. Swallow CJ, Strauss DC, Bonvalot S, Rutkowski P, Desai A, Gladdy RA, et al. Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic australasian RPS Working Group. Ann Surg Oncol 2021; 28: 7873–88. doi: <a href="https://doi.org/10.1245/s10434-021-09654-z" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1245/s10434-021-09654-z</a>
  79. Fearon KC, Luff R. The nutritional management of surgical patients: enhanced recovery after surgery. Proc Nutr Soc 2003; 62: 807–11. doi: <a href="https://doi.org/10.1079/PNS2003299" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1079/PNS2003299</a>
DOI: https://doi.org/10.2478/raon-2024-0013 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 110 - 123
Submitted on: Jul 26, 2023
Accepted on: Nov 3, 2023
Published on: Feb 21, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2024 Manuel Ramanovic, Marko Novak, Andraz Perhavec, Taja Jordan, Karteek Popuri, Nada Rotovnik Kozjek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.